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Total hip arthroplasty (THA) has proven to be an excellent 
treatment for treating osteoarthritis of the hip. Since Sir John 
Charnley, the metal-on-polyethylene (MoP) bearing has been 
the gold standard, outperforming 1st-generation metal-on-
metal (MoM) THAs like the McKee THA.1 However, poly-
ethylene (PE) wear leading to particle-induced osteolysis and 
component loosening has been considered a drawback of the 
MoP articulation couple. Therefore, in the late 1980s, 2nd-
generation MoM bearings were developed, with improve-
ments in fixation, metallurgy, sphericity and radial clearance. 
These new MoM designs showed promising wear perfor-
mance,2,3 but as there was a lack of comparative clinical trials, 
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Abstract
Background: Metal-on-metal total hip arthroplasty (MoM THA) is associated with the formation of pseudotumours. 
Studies mainly concern pseudotumour formation in large head MoM THA. We performed a long-term follow-up 
study, comparing pseudotumour incidence in small head metal-on-metal (SHMoM) THA with conventional metal-on-
polyethylene (MoP) THA. Predisposing factors to pseudotumour formation were assessed.
Methods: From a previous randomised controlled trial comparing SHMoM (28 mm) cemented THA with conventional 
MoP cemented THA, patients were screened using a standardised CT protocol for the presence of pseudotumours. 
Serum cobalt levels and functional outcome were assessed.
Results: 56 patients (33 MoP and 23 MoM) were recruited after mean follow-up of 13.4 years (SD 0.5). The incidence 
of pseudotumours was 1 (5%) in the SHMoM THA cohort and 3 (9%) in the MoP THA cohort. Prosthesis survival was 
96% for both SHMoM and MoP THAs. Serum cobalt levels did not exceed acceptable clinical values (<5 µg/L) whereas 
no differences in cobalt levels were detected at follow-up between both groups. Oxford and Harris Hip Scores were 
good and did not differ between SHMoM and MoP THA.
Conclusions: This long-term follow-up study shows a low incidence of pseudotumour formation and good functional 
outcome in cemented head-taper matched SHMoM and MoP THA.
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in the late 1990s our institute performed a randomised con-
trolled trial (RCT) to compare clinical performance of small 
head (SH) MoM with small head MoP THA (both 28-mm 
femoral head diameter). Secondary outcomes were cobalt ion 
levels, radiology and survival. The 5- and 10-year follow-up 
data have been published previously, showing no difference 
in clinical performance.4,5
During follow-up, due to reports of possible pseudotu-
mour formation and increased ion levels in large head 
THA and resurfacing MoM articulations,6 our institute 
decided to recall all MoM THA patients. All available 
patients were screened for the presence of pseudotumours 
according to the guidelines issued by the Dutch Orthopaedic 
Society.7 The MoP study cohort of the RCT was screened 
as well, in order to compare both MoM and MoP cohorts.
The primary aim of this study was to compare the inci-
dence of pseudotumours in SHMoM THA with conven-
tional MoP THA after long-term follow-up. The secondary 
aim was to compare cobalt levels, functional outcome and 
radiological outcome in both groups to assess their rela-
tionship to articulation type and pseudotumour formation.
Materials and methods
The initial study compared cemented SHMoM THA with 
MoP THA.4 Study design and procedures were approved by 
the local Medical Ethics Committee (METC 97-19). Patients 
included suffered from non-inflammatory degenerative 
joint disease of the hip. 5 orthopaedic surgeons and 2 ortho-
paedic residents performed the surgery via a posterolateral 
or direct lateral approach in lateral decubitus position.
Randomisation was based on sequentially numbered 
opaque sealed envelopes, produced by an external institu-
tion not involved in the selection, care or evaluation of the 
patients.
The MoM patient group (101 patients, 102 hips) 
received an M2A cup (Biomet, Warsaw, IN, USA), manu-
factured by moulding a block of conventional PE (ArCom, 
Biomet) around a highly-polished cobalt-chromium-
molybdenum alloy bearing insert. The MoP patient group 
(97 patients, 98 hips) received a cemented conventional 
PE acetabular component (ArCom, Biomet). A Stanmore 
cemented femoral stem was used, combined with a 28-mm 
modular femoral head, both made of a cobalt-chromium-
molybdenum alloy.
Screening protocol
99 out of 195 patients participating in the original RCT were 
found to be eligible and were contacted for pseudotumour 
screening. The other 96 patients were excluded because they 
were deceased (90) or had undergone revision surgery (6) 
during follow-up (Figure 1). 29 patients had undergone a 
contralateral (non-RCT) MoP THA, which was also 
included in the pseudotumour screening. The screening pro-
tocol consisted of a radiological assessment (plain 
radiograph of the pelvis and computed tomography [CT]), 
assessment of functional outcome (Oxford Hip Score 
[OHS]8 and Harris Hip Score [HHS]9) and measurements of 
serum cobalt levels. In total 56 patients responded to the 
recall (33 MoP THA and 23 MoM THAs) (Figure 2). There 
were 43 non-responders: three patients refused to cooperate, 
one patient had dementia and the other 39 (19 MoM, 21 
MoP) patients were lost to follow-up and could not be 
traced. The baseline characteristics of the 2 groups were 
comparable, except for the surgical approach, with a mean 
age of almost 80 years at follow-up (Table 1). The local 
Medical Ethics Committee approved the procedures 
employed in this study (METC 2011-44).
Radiological evaluation
Conventional hip radiographs as well as computed tomogra-
phy were performed. We used CT as cross modality imaging 
of choice over MRI as it is less expensive and more readily 
Figure 1. Flow chart of the randomised controlled trial.
*incl 5 bilateral THAs: 1 MoM/MoM, 1 MoP/MoP, 3 MoP/MoM.
#total revisions for aseptic loosening, cultures negative.
§2 acetabular revisions for aseptic loosening (one suggestive of ALVAL), 
1 acetabular revision for instability, 1 prosthesis removal (girdlestone) 
for aseptic loosening.
$1 bilateral MoM/MoM, 2 bilateral MoM/MoP, 1 bilateral MoP/MoP.
Figure 2. Flow chart of the 56 patients involved in 
pseudotumour screening.
Nota bene: 29 patients with contralateral non-RCT MoP THA (27 uni-
lateral patients left for cobalt and HHS/OHS measurements).
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available than magnetic resonance imaging (MRI) and has 
been shown to be a good predictor of revision in relevant 
cases.10–12 CT scans were obtained using a 16-slice CT scan-
ner (Philips, Best, The Netherlands) and viewed in a bone 
window to minimise metal artifact without the use of a 
metal suppression protocol. Window-width to window-level 
values were set at 2000:650. A CT grading system was used 
to describe the amount of postoperative synovial reaction 
(Table 2).13 Grade IV or V findings, which consist of a solid, 
semisolid, or cystic eccentric extension of the capsule, 
resulting in an increase in the volume of the capsule that 
could not be attributed to an infection, malignancy, bursal or 
scar tissue were classified as a pseudotumour. No minimum 
size was applied to define a pseudotumour. All CT scans 
were performed and reviewed by an experienced musculo-
skeletal radiologist (MFB) using the same protocol as previ-
ous studies on MoM THA10,14,15
The inclination of the acetabular component was meas-
ured on a supine anteroposterior pelvic hip radiograph. 
Inclination angles which exceeded 50° were regarded as 
outliers.16,17 Acetabular radiolucent lines were described 
according to Delee and Charnley,18 femoral radiolucent 
lines were described according to Gruen et al.19 
Radiological cup loosening was defined according to the 
Zicat criteria.20 Polyethylene wear was estimated using 
single image analysis with Roman software.21
Serum cobalt
Serum cobalt levels were measured using inductively 
coupled plasma mass spectrometry (ICP-MS; Agilent 
7500 series, Agilent Technologies, Lexington, MA, 
USA). The reference value (defined as the upper limit 
in the general population) for cobalt in our laboratory 
was <0.40 µg/L. On the basis of guidelines from the 
Dutch Orthopaedic Society, serum cobalt levels were 
defined as being elevated when they equalled or 
exceeded 5.0 µg/L.7
Functional outcome
Patients completed the OHS as part of their clinical assess-
ment. The HHS was assessed by an orthopaedic nursing 
specialist. Assessors and patients were not blinded.
Statistical analysis
Descriptive statistics were used to describe the demo-
graphic characteristics of the study population. Binary 
logistic regression analysis was performed to assess dif-
ferences in the risk of pseudotumour formation between 
MoM THA and MoP THA. Gender and follow-up time 
were checked for confounding or effect modification. 
Additionally, we investigated whether having a pseudo-
tumour on the contralateral (non-index) side would have 
an effect on the incidence of pseudotumours on the index 
side. For effect modification, a p value of ⩽0.10 of 
the interaction term was used to indicate significance. 
For the analyses of cobalt levels and functional 
outcome (OHS and HHS), only patients with a unilateral 
THA (n = 27) were included as bilateral THAs may 
affect serum cobalt levels and functional outcome. 
Table 1. Demographics and surgical characteristics MoM versus MoP.
MoM THA (n = 23) MoP THA (n = 33) p-value
Sex (male/female) 6/17 7/26 0.67
Mean age (years (SD)) 78.8 (5.7) 78.7 (6.5) 0.93
Mean follow-up (years (SD)) 13.2 (0.4) 13.5 (0.5) 0.06
Surgical approach (posterolateral/direct lateral) 19/4 19/14 <0.05
MoM, metal-on-metal; MoP, metal-on-polyethylene.
Table 2. CT-grading system for pseudotumours.13
Grade Description Criteria
I Normal or acceptable thickening of the capsule up to 4–6 mm.
II Reactive thickened capsule >6 mm with or without bulging but not more than the neck of 
the prosthesis and without eccentric enlargement with regard to the capsule
III Mild MoM disease consists of a bulging capsule both anterior and posterior
IV Moderate MoM disease represents eccentric bulging or enlargement of the capsule, which is often seen 
inferomedial to the prosthetic head
V Severe MoM disease is reserved for the so-called bursitis mimicker, often posterolaterally with 
extensive filling of the bursa subtrochanterica, or anteriorly by filling of the 
bursa iliopectinea, which can extend quite impressively into the abdominal 
compartment
MoM, metal-on-metal.
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The Mann–Whitney U-test was used to determine a sig-
nificant difference in serum cobalt levels at recall between 
MoM and PE. Chi-square and Fisher’s exact tests were 
used to assess associations between cobalt ion levels and 
pseudotumour formation, and between inclination of the 
acetabular component, pseudotumour formation and 
serum cobalt levels. To assess differences in (the recov-
ery of) physical functioning between the MOM and PE 
group, generalised estimating equations (GEE) analyses 
were performed (exchangeable working correlation 
structure and robust estimation of the covariance matrix). 
Data were checked for effect modification and existence 
of confounding factors.
Statistical analysis was performed using IBM-SPSS 
Statistics v23 (IBM, Armonk, NY, USA). A p value ⩽0.05 
was considered to be statistically significant.
Results
The mean duration of follow-up at the time of recall was 
13.4 years (standard deviation [SD] 0.5; range 13–14 
years). Survival was 96% for both MoM and MoP THAs 
(Figure 3). None of the revisions was primary pseudotu-
mour-related, however in one MoM acetabular revision 
(33 months p.o.) because of component loosening, histol-
ogy was suggestive of ALVAL (Figure 1).
CT
54 patients (22 MoM, 32 MoP) had a CT scan (2 patients 
refused due to claustrophobia). Of these, 1 MoM (4.5%) 
and 3 MoP THAs (9.4%) were classified as having a pseu-
dotumour (p = 0.64). 1 patient (MoP) had a pseudotumour 
on the contralateral (non-index) side. Logistic regression 
analysis of articulation type and pseudotumour incidence 
determined gender and follow-up time to be significant 
confounders, and no effect modification was observed.
Cobalt
Of the 56 patients, 27 had a unilateral THA (10 MoM, 17 
MoP). These patients were included in the analyses of 
cobalt levels. None of these patients had elevated cobalt 
levels. Taking the patients with bilateral THAs into account 
as well, additionally only one patient had cobalt levels ⩾5 
µg/L (7.39 µg/L). This was a female with a MoM THA and 
a contralateral non-RCT MoP cemented THA with no 
signs of pseudotumour on CT and well-functioning hips 
(HHS 91, OHS 20). As a consequence, none of the patients 
with a pseudotumour on CT showed elevated cobalt 
levels.
At recall, median cobalt levels did not differ between 
MoM (1.25 µg/L, range 0.34–4.09) and MoP THA (0.6 
µg/L, range 0.5–4.0).
Figure 3. Kaplan–Meier survival curve describing survival of both MoM and MoP THAs after a mean follow-up of 13.4 years.
Endpoint was defined as revision of any component.
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In both groups, cobalt levels gradually increased over 
time. However, no difference between groups were noted 
and, overall, cobalt levels did not exceed acceptable clini-
cal values.
Radiological outcome
Radiographs were obtained from all 56 patients and ace-
tabular component inclination angles were measured for 
all 56 patients. Both groups, MoM and MoP, showed com-
parable inclination ranges. No correlation could be found 
between higher inclination values and elevated cobalt lev-
els or the existence of pseudotumours.
Periprosthetic radiolucent lines were observed in MoM 
as well as MoP THAs. However, no differences in pattern 
or incidence of radiolucent lines were found between 
either of these groups (Table 3). Furthermore, no correla-
tion was found between radiolucent lines and pseudotu-
mour existence. Radiological loosening was seen in 1 
MoM (cup + stem) and 1 MoP (cup) THA. The first 
patient (aged 89) was wheelchair-bound (due to severe 
epilepsy and after contralateral hip surgery) and declined 
a revision operation (HHS 53, OHS 38). The second 
patient (aged 83) was asymptomatic (HHS 90, OHS 26), 
with no signs of excessive PE wear. PE wear was deter-
mined for all 33 MoP THAs. The mean overall PE wear 
was 1.6 mm (SD 0.7). The 2 MoP THAs associated with 
pseudotumour formation on CT did not show excessive 
PE wear (resp. 0.9 and 1.3 mm).
Functional outcome
Functional outcome (HHS and OHS) did not differ 
between MoM and MoP THA (Table 4). Also, the presence 
of a pseudotumour did not significantly influence the HHS 
or OHS (Table 5).
Discussion
The primary objective of this study was to compare the 
incidence of pseudotumours in SHMoM THA with con-
ventional MoP THA after long-term follow-up. Both types 
of THA showed a comparable low incidence of pseudotu-
mour formation of 4.5% and 9.4% respectively after a 
mean follow-up of >13 years. In our recent study on pseu-
dotumour incidence in LHMoM THA versus conventional 
MoP THA, remarkably much higher incidences were 
found (53.7% and 21.8% resp.), using the same 
CT-screening protocol.15 We stated pseudotumour forma-
tion to be caused by an adverse tissue reaction to metal 
debris (ARMD) and it also, hypothetically at least in MoP 
THAs, could be a consequence of an adverse reaction to 
polyethylene particles (‘particle disease’). Several sugges-
tions can be made to explain the differences we found in 
radiological pseudotumour incidence between the SHMoM 
and LHMoM THA in our two studies. The most important 
point is the fact that, apart from the different femoral head 
sizes, different taper connections have been used. In our 
previous study, the large head (38–60 mm) MoM THA 
consisted of a titanium stem taper-adapter junction and a 
cobalt-chromium head and shell. The small head (28 mm) 
Table 3. Number of hips with radiolucent lines at recall.
Zone MoM (n = 23) MoP (n = 33) p value
Stem (Gruen)  
1 2 3 1.00+
2 1 0 0.41+
3 1 0 0.41+
4 1 0 0.41+
5 1 0 0.41+
6 1 1 1.00+
7 1 1 1.00+
Cup (Delee)  
1 9 12 0.83*
2 3 8 0.50+
3 3 5 1.00+
No of hips with 
radiolucency
10 (43%) 16 (48%) 0.71
MoM, metal-on-metal; MoP, metal-on-polyethylene.
*Chi-square test.
+Fisher’s Exact test.





Prosthesis type 1.0 (−1.6 – 3.6) 0.45
Time Preoperative 0a  
5 year 40.1 (35.9 – 44.4) <0.001
10 year 39.4 (35.8 – 43.0) <0.001
Recall 37.1 (32.6 – 41.6) <0.001
CI, confidence interval; Reference group: PE.
aSet to zero because the preoperative measurement was used as refer-
ence.





Prosthesis type 0.6 (−2.0 − 3.3) 0.64
Time Preoperative 0a  
5 year −23.5 (−25.8 −21.2) <0.001
10 year −16.2 (−19.2 −13.2) <0.001
Recall −15.3 (−18.4 −12.2) <0.001
CI, confidence interval; Reference group: PE.
aSet to zero because the preoperative measurement was used as refer-
ence.
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Stanmore MoM THA used in our present study consists of 
a cobalt-chromium stem taper connecting with a cobalt-
chromium head and acetabular inlay. It is known that dis-
similar alloy combinations in taper connections are more 
prone to galvanic and fretting corrosion.22,23
Another factor is the increased moment arm from the 
centre of the head to the centre of the pressure on the trun-
nion in the LHMoM THAs. This leads to increased torsion 
and friction at the taper junction, resulting in increased 
corrosion and eventually even in taper fractures.22,24 
Furthermore, the use of the adapter-sleeve in the LHMoM 
THA cohort results in three taper junctions potentially con-
tributing to corrosion and metal debris formation.
As there was a lower incidence of pseudotumours in 
SHMoM THA, there also was a lower incidence of pseu-
dotumour (9.4%) in the cemented MoP THA study 
cohort in comparison with the incidence (21.8%) in our 
previous study with uncemented MoP THA. Again, a 
possible explanation could be the taper connection. The 
cemented Stanmore MoP THA in the present study has a 
CoCr-CoCr stem taper-head connection, whereas the 
uncemented Malloryhead MoP THA of our former study 
consists of a Ti-CoCr taper connection; again, a dissimi-
lar alloy combination, causing galvanic and fretting 
corrosion.
Survival, defined as revision for any reason, after 13.4 
years was 96% for both MoM and MoP THAs in our 
study. Considering the NICE criteria (hip arthroplasties 
should have an overall survival after 10 years of >95%),25 
we can assume that the SHMoM THA is a suitable option 
for clinical practice. Previous studies with comparable 
follow-up but in younger patients (under and around 50 
years of age) also reported rather reasonable survival 
rates in SHMoM THAs.26–30
Recently Lombardi et al.31 published results on their 
experience with a SHMOM THA (uncemented M2a 
Taper). Aseptic component survival after 10 years was 
96%, after 15 years 92% and after 19 years 73%. 70% of 
revisions (14/20) performed were related to ARMD. 
Lübbeke et al.32 compared SHMoM THAs (Metasul 
inlay in metal-backed uncemented titanium shell with 
PE surface) with CoP (ceramic on PE) THAs and 
reported an incidence of 1.1% ARMD in revisions of 
MoM THAs. After 10 years the revision rate clearly 
increased for the MoM cohort, probably due to late 
adverse reactions to metal. All pseudotumours occurred 
in THAs in which revisions were performed more than 
12 years postoperatively. Survival of MoM and CoP 
cohorts were comparable after 10 years of follow-up; 
however, after 12 years the MoM cohort showed a sig-
nificantly decreased survival (91.7% vs. 97.7%). These 
data suggest that an excellent 10-year survival, as in our 
study, does not preclude future failures in the longer 
term relating to MoM articulation, especially during the 
second decade. But again, these 2 studies also report on 
SHMoM THAs containing titanium stems or titanium 
acetabular shells, which makes extrapolation of results 
to our cemented CoCr head-taper matched MoM THAs 
difficult. Of note, several of the previously mentioned 
long-term follow-up studies on SHMoM THAs involved 
much younger patients than our study population,26–30 so 
it seems that younger age and (hence) a more active life-
style does not influence the outcome.
The secondary aim of our study was to compare cobalt 
levels, functional outcome and radiological outcome in 
both groups to assess their relationship to articulation type 
and pseudotumour formation. Cobalt levels did not 
increase above critical levels (>5 µg/L), except for 1 
patient with a bilateral THA (MoM/MoP). This is in 
accordance with the finding that no cases of ARMD were 
described in our SHMoM THA group. Hallows et al.33 
studied cementless SHMOM (28–32 mm), LHMoM (>38 
mm) and conventional MoP (28–36 mm) as control groups. 
Cobalt levels of the MoM THAs were significantly 
increased as compared with the (MoP) control group. All 
these THAs, however, consisted of cementless titanium 
stems coupled with cobalt-chromium heads. In our study, 
we combined cemented cobalt-chromium-molybdenum 
stems with cobalt-chromium heads, which could possibly 
explain our finding of lower cobalt levels. We could not 





Pseudotumour −6.8 (−15.4–1.7) 0.12
Time Preoperative 0a  
5 year 40.1 (35.7–44.5) <0.001
10 year 39.6 (35.9–43.3) <0.001
Recall 36.9 (32.3–41.5) <0.001
CI, confidence interval.
Reference group: no pseudotumour.
aSet to zero because the preoperative measurement was used as refer-
ence.
Table 5b. Results of GEE analysis of Oxford Hip Scores per 
presence of pseudotumour.
Effect Regression coefficient 
(95% CI)
p value
Pseudotumour 0.8 (−3.7 – 5.4) 0.72
Time Preoperative 0a  
5 year −23.4 (−25.8 −21.1) <0.001
10 year −16.4 (−19.5 −13.3) <0.001
Recall −14.9 (−18.1 −11.8) <0.001
CI, confidence interval.
Reference group: no pseudotumour.
aSet to zero because the preoperative measurement was used as refer-
ence.
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find any other comparative study reporting on cobalt levels 
in THAs with this particular taper/head combination.
Radiological outcome did not show any differences 
between the MoM and MoP patient groups. Functional 
outcome was comparable between two groups. Because of 
the low incidence of pseudotumours, no relation could be 
found between radiological outcome, functional outcome 
and the existence of a pseudotumour.
This study has its limitations. We were not able to 
describe a complete follow-up of the original study 
cohorts. Due to the relatively older patient population 
(mean age around 70 years at surgery), a significant num-
ber of patients (90) died within this long-term follow-up. 
Another issue is the relatively large number of patients 
lost to follow-up. This was, however, in line with our 
expectations, considering the number of patients available 
for the 10-year report on these cohorts.5 In order to esti-
mate the outcome effect of the non-responders, we per-
formed a non-response analysis. Non-responders differed 
only in age (83.7 vs. 78.7 years). For gender, prosthesis 
type and functional outcome (as measured at 10-year fol-
low-up) no differences were found.
In spite of these limitations, we were able to present a 
long-term follow-up of 2 comparable cohorts of small 
head MoM and MoP THAs regarding pseudotumour inci-
dence, ion levels and functional outcome.
Conclusion
We report good implant survival in cemented head-taper 
matched small head MoM THA after 13.4 years of clinical 
follow-up with a low incidence of pseudotumour forma-
tion and cobalt levels comparable with MoP THA. 
Functional outcome was good for patients with both 
SHMoM and MoP THAs.
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